Drug intelligence / Profile preview

PLK4 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intrathecal, Topical, Parenteral
01

Overview

PLK4 siRNA is a small interfering RNA (siRNA) designed to target and silence the expression of Polo-like kinase 4 (PLK4), a key regulator of centriole duplication and cell division. PLK4 is frequently upregulated in various cancers, including breast and colorectal cancers, where its overexpression leads to centrosome amplification and chromosomal instability. By mediating the sequence-specific degradation of PLK4 mRNA, PLK4 siRNA inhibits cancer cell proliferation, induces mitotic arrest, and promotes apoptosis. In addition to oncology research, PLK4 siRNA has been investigated in preclinical models of spinal cord injury to reduce astrocyte proliferation and neuroinflammation. It is widely utilized as a research reagent to study centrosome biology and validate PLK4 as a therapeutic target.

Other names
PLK4 small interfering RNAPLK-4 small interfering RNAPLK 4 small interfering RNAPlk4-siRNAPlk-4-siRNAPlk 4-siRNApolo-like kinase 4 siRNApolo-like kinase 4 small interfering RNA
02

Targets

PLK4 (Polo-like kinase 4)

Beyond the preview

Go deeper on PLK4 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLK4 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call